LaSalle, Canada

Josef Roland Bencsik

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Array Biopharma Inc.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Josef Roland Bencsik. Retrieved from https://idiyas.com/inventor/josef-roland-bencsik

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Josef Roland Bencsik

Introduction

Josef Roland Bencsik is a notable inventor based in LaSalle, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific medical conditions. His work is characterized by a focus on innovative solutions for complex health issues.

Latest Patents

Bencsik holds a patent for "Piperidinyl-substituted lactams as GPR119 modulators." This patent describes compounds that are modulators of GPR119 and are useful in the treatment or prevention of diseases such as type 2 diabetes, diabetic complications, metabolic syndrome, obesity, dyslipidemia, and related conditions. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Bencsik has worked with Array Biopharma Inc., where he has been instrumental in developing new therapeutic approaches. His expertise in pharmacology and compound development has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Bencsik has collaborated with notable colleagues such as Scott Alan Pratt and Ajay Singh. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Josef Roland Bencsik's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his dedication to improving health outcomes. His work continues to influence the development of treatments for various medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…